We are hereby submitting the financial results under regulation 33 of SEBI (LODR) Regulation, 2015, board of director considered and approved in board meeting held on 14th November and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharpline Broadcast's board meeting, originally scheduled for November 14, was adjourned multiple times due to financial observations raised by statutory auditors and delays in receiving required financial statements, finally concluding on November 18, 2025. On a standalone basis, H1 FY26 revenue grew about 41% year-on-year to ₹2,166.24 lakhs, but the company slipped deeper into losses with a net loss of ₹487.10 lakhs versus ₹456.41 lakhs in H1 FY25. On a consolidated basis, revenue jumped sharply to ₹5,048.81 lakhs (up from ₹1,531.56 lakhs), largely driven by a new Medicine segment, yet the group reported a loss of ₹443.64 lakhs. Operating cashflow turned sharply negative at around negative ₹1,193 lakhs compared to a positive ₹223.66 lakhs a year ago. Total consolidated borrowings rose to about ₹2,607 lakhs against equity of ₹2,384 lakhs, pushing the debt-to-equity ratio above 1. The statutory auditor (BAS & Co. LLP) issued an unqualified limited review report.
Despite strong top-line growth, widening losses, negative operating cashflows, rising debt, and the unusual delay in finalising results with auditor concerns are significant red flags for shareholders. The stock could face negative sentiment and volatility when trading resumes on November 21, 2025.